The EMERALD Trial: Elacestrant in Patients with HR , HER2- Advanced Breast Cancer | OncLive
The EMERALD Trial: Elacestrant in Patients with HR , HER2- Advance…
Feb 9, 2024
onclive.com
The Role of Elacestrant in Breast Cancer | OncLive
The Role of Elacestrant in Breast Cancer | OncLive
Jan 30, 2024
onclive.com
Real-World Data: Elacestrant for ESR1m, ER , HER2- MBC | Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
Real-World Data: Elacestrant for ESR1m, ER , HER2- MBC | Targete…
8 months ago
targetedonc.com
Dr. Lin on the Advantage of Elacestrant in ESR1-Mutated Breast Cancer
Dr. Lin on the Advantage of Elacestrant in ESR1-Mutated Brea…
Jun 14, 2022
onclive.com
Considering Elacestrant in ESR1 Breast Cancer After CDK4/6 Inhibition | Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
Considering Elacestrant in ESR1 Breast Cancer After CDK4/6 Inhibi…
Feb 17, 2025
targetedonc.com
The EMERALD Trial: Elacestrant Mechanism of Action, Study Design, and Outcomes | Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
The EMERALD Trial: Elacestrant Mechanism of Action, Study Desig…
Nov 9, 2022
targetedonc.com
Elacestrant + Targeted Therapy for ER+/HER2– Metastatic Breast Cancer: Early Phase Trial Findings | Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
Elacestrant + Targeted Therapy for ER+/HER2– Metastatic Breast Can…
6 days ago
targetedonc.com
2:01
Real-World Data Reveal Longer PFS With Elacestrant in Breast Cancer …
10 months ago
targetedonc.com
1:44
Dr Rugo on Elacestrant-Based Combinations in ER /HER2– Metas…
Dec 11, 2024
onclive.com
ER metastatic breast cancer: Key insights on elacestrant from the la…
11 months ago
apple.com
EMERALD: Elacestrant in ER /HER2- Advanced Breast Cancer | OncLive
Jan 23, 2024
onclive.com
Dr Bardia on the Investigation of Elacestrant vs Endocrine Therapy …
2 weeks ago
onclive.com
Dr. Bardia on Elacestrant in ER+/HER2– Metastatic Breast Can…
2 weeks ago
onclive.com
EMERALD Phase 3 Trial of Elacestrant Versus Standard of Ca…
Dec 22, 2022
onclive.com
6:07
Elacestrant real-world progression-free survival (rwPFS) of adult patie…
1 week ago
onclive.com
Tumore: elacestrant nuova terapia in aiuto a pazienti con carcinoma …
Jun 20, 2024
Il Sole 24 ORE
Overview of phase 3 EMERALD study of elacestrant for ER+, HER…
1 week ago
targetedonc.com
Dr. Bidard on the FDA Approval of Elacestrant in ER /HER2– Metastat…
Feb 8, 2023
onclive.com
0:50
FDA approves Elacestrant (Orserdu) for ER-positive, HER2-negative, E…
1.3K viewsJan 29, 2023
YouTubemedXclusive Learning
1:07
Tumori: oncologa Del Mastro, 'elacestrant passo avanti in cura c…
3 weeks ago
MSNAdnkronos
SABCS 2022 EMERALD Phase 3 Trial Updated Results by Duration …
1.7K viewsDec 14, 2022
vumedi.com
2:35
Dr Lloyd on the Effects of ESR1 Mutations on Elacestrant Outcom…
126 viewsDec 13, 2024
YouTubeOncLive
Imlunestrant vs Elacestrant: MOA and Clinical Trial Differences | On…
4 months ago
oncnursingnews.com
20:05
ESR1 Mutation: The Need for & Role of Testing in ER+/ HER2- Advance…
956 viewsSep 21, 2023
YouTubeCOR2ED The Heart of Medical Education
Advanced HR+ BC: Elacestrant vs. ET, Alpelisib/Inavolisib for PIK3CA…
284 viewsMar 4, 2024
vumedi.com
0:57
Dr Kaklamani on the Effects of VAF on Elacestrant Outcomes in ER+ B…
104 viewsDec 11, 2024
YouTubeOncLive
8:53
Elacestrant in ER+/HER2- mBC with ESR1-mut tumors: Overview of th…
3K views10 months ago
YouTubeCOR2ED The Heart of Medical Education
2:37
Elacestrant: A New Weapon Against Advanced Estrogen Receptor-Posi…
981 viewsApr 17, 2024
YouTubePharmacology Insights
7:37
Identifying ESR1 Mutations for ORSERDU Eligibility
239.7K views7 months ago
YouTubeORSERDU® (elacestrant) HCP
See more videos
Static thumbnail place holder